Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
(NASDAQ: INBX) Delayed: 121.17 -1.09 (0.89%)
Previous Close $122.26    52 Week High $ 
Open $121.04    52 Week Low $ 
Day High $124.19    P/E N/A 
Day Low $120.48    EPS $ 
Volume 192,121